Parries et al., 1995 - Google Patents
The human urinary epidermal growth factor (EGF) precursor: isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl …Parries et al., 1995
View HTML- Document ID
- 8206414013718484510
- Author
- Parries G
- Chen K
- Misono K
- Cohen S
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
In this report, we describe the isolation from human urine of a predominant 160-kDa epidermal growth factor (EGF)-immunoreactive glycoprotein that exhibits affinity for heparin. The purification procedure involved concentration and dialysis of 20-30-liter batches of fresh …
- 101700033006 EGF 0 title abstract description 188
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hallahan et al. | Dual site model for the organogenic activity of angiogenin. | |
| US5453492A (en) | 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β | |
| Kobayashi et al. | The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. | |
| US6022540A (en) | Ligands that modulate differentiation of mesenchymal stem cells | |
| Parries et al. | The human urinary epidermal growth factor (EGF) precursor: isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus | |
| Hu et al. | An angiogenin-binding protein from endothelial cells. | |
| Linder et al. | Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms | |
| Dong et al. | Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains | |
| JPH08503198A (en) | OP-3 induced morphogenesis | |
| Garcia et al. | An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin. | |
| US5874277A (en) | Proteins, their production and use | |
| Vallee et al. | Organogenesis and angiogenin | |
| Breyer et al. | The epidermal growth factor precursor isolated from murine kidney membranes. Chemical characterization and biological properties. | |
| Riordan | Structure and function of angiogenin | |
| EP0342219A1 (en) | Protein homologue of human angiogenine | |
| EP0973914B1 (en) | Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use | |
| US5876713A (en) | Glutamine: fructose-6-phosphate amidotransferase, its production and use | |
| WO2000073427A2 (en) | Acetylcholinesterase-derived peptides and uses thereof | |
| EP0897426B1 (en) | Matrix metalloprotease | |
| DE69530261T2 (en) | Protein tyrosine phosphatases stimulated by cell density | |
| Szoka et al. | Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts | |
| Ishibe et al. | Activation of osteoblast insulin-like growth factor-II/cation-independent mannose-6-phosphate receptors by specific phosphorylated sugars and antibodies induce insulin-like growth factor-II effects | |
| WO2005093057A1 (en) | Truncated dance, dance complex and method of using these | |
| Helwig et al. | Isolation and characterization of a microvascular fraction from rabbit kidney cortex | |
| Vallee et al. | Chemical and biochemical properties of human angiogenin |